Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 19938038)

1.

Blood Pool Contrast-enhanced Magnetic Resonance Angiography with Correlation to Digital Subtraction Angiography: A Pictorial Review.

Knuttinen MG, Karow J, Mar W, Golden M, Xie KL.

J Clin Imaging Sci. 2014 Nov 29;4:63. doi: 10.4103/2156-7514.145860. eCollection 2014.

2.

Type of MRI contrast, tissue gadolinium, and fibrosis.

Do C, Barnes JL, Tan C, Wagner B.

Am J Physiol Renal Physiol. 2014 Oct 1;307(7):F844-55. doi: 10.1152/ajprenal.00379.2014. Epub 2014 Aug 6.

PMID:
25100280
3.

Redox- and hypoxia-responsive MRI contrast agents.

Do QN, Ratnakar JS, Kovács Z, Sherry AD.

ChemMedChem. 2014 Jun;9(6):1116-29. doi: 10.1002/cmdc.201402034. Epub 2014 May 13. Review.

4.

Gadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.

Richardson OC, Bane O, Scott ML, Tanner SF, Waterton JC, Sourbron SP, Carroll TJ, Buckley DL.

Magn Reson Med. 2014 Feb 11. doi: 10.1002/mrm.25128. [Epub ahead of print]

5.

Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.

Lux J, Chan M, Elst LV, Schopf E, Mahmoud E, Laurent S, Almutairi A.

J Mater Chem B Mater Biol Med. 2013 Dec 14;1(46):6359-6364.

6.

Environmentally responsive MRI contrast agents.

Davies GL, Kramberger I, Davis JJ.

Chem Commun (Camb). 2013 Oct 28;49(84):9704-21. doi: 10.1039/c3cc44268c. Review.

7.

Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.

Avedano S, Botta M, Haigh JS, Longo DL, Woods M.

Inorg Chem. 2013 Aug 5;52(15):8436-50. doi: 10.1021/ic400308a. Epub 2013 Jul 10.

8.

Synthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imaging.

Ye Z, Wu X, Tan M, Jesberger J, Grisworld M, Lu ZR.

Contrast Media Mol Imaging. 2013 May-Jun;8(3):220-8. doi: 10.1002/cmmi.1520.

9.

3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.

Raman FS, Nacif MS, Cater G, Gai N, Jones J, Li D, Sibley CT, Liu S, Bluemke DA.

Int J Cardiovasc Imaging. 2013 Jun;29(5):1085-94. doi: 10.1007/s10554-013-0192-z. Epub 2013 Mar 21.

10.

Molecular MRI of liver fibrosis by a peptide-targeted contrast agent in an experimental mouse model.

Chow AM, Tan M, Gao DS, Fan SJ, Cheung JS, Qiao Z, Man K, Lu ZR, Wu EX.

Invest Radiol. 2013 Jan;48(1):46-54. doi: 10.1097/RLI.0b013e3182749c0b.

11.

The protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonance.

Kawel N, Santini F, Haas T, Froehlich JM, Bremerich J.

J Cardiovasc Magn Reson. 2012 Oct 15;14:71. doi: 10.1186/1532-429X-14-71.

12.

Nanotechnology applications for glioblastoma.

Nduom EK, Bouras A, Kaluzova M, Hadjipanayis CG.

Neurosurg Clin N Am. 2012 Jul;23(3):439-49. doi: 10.1016/j.nec.2012.04.006. Epub 2012 Jun 14. Review.

13.

An extracellular MRI polymeric contrast agent that degrades at physiological pH.

Schopf E, Sankaranarayanan J, Chan M, Mattrey R, Almutairi A.

Mol Pharm. 2012 Jul 2;9(7):1911-8. doi: 10.1021/mp2005998. Epub 2012 Jun 13.

14.

Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance.

Reiter T, Ritter O, Prince MR, Nordbeck P, Wanner C, Nagel E, Bauer WR.

J Cardiovasc Magn Reson. 2012 May 20;14:31. doi: 10.1186/1532-429X-14-31. Review.

15.

T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.

Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA.

J Cardiovasc Magn Reson. 2012 Apr 28;14:26. doi: 10.1186/1532-429X-14-26.

16.

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.

Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG.

Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1. Review.

17.

Gd₂O₃ nanoparticles in hematopoietic cells for MRI contrast enhancement.

Hedlund A, Ahrén M, Gustafsson H, Abrikossova N, Warntjes M, Jönsson JI, Uvdal K, Engström M.

Int J Nanomedicine. 2011;6:3233-40. doi: 10.2147/IJN.S23940. Epub 2011 Dec 9.

18.

Overcoming the low relaxivity of gadofosveset at high field with spin locking.

Richardson OC, Scott ML, Tanner SF, Waterton JC, Buckley DL.

Magn Reson Med. 2012 Oct;68(4):1234-8. doi: 10.1002/mrm.23316. Epub 2011 Dec 9.

19.

Polydisulfide manganese(II) complexes as non-gadolinium biodegradable macromolecular MRI contrast agents.

Ye Z, Jeong EK, Wu X, Tan M, Yin S, Lu ZR.

J Magn Reson Imaging. 2012 Mar;35(3):737-44. doi: 10.1002/jmri.22848. Epub 2011 Oct 26.

20.

PET Imaging and Biodistribution of Silicon Quantum Dots in Mice.

Tu C, Ma X, House A, Kauzlarich SM, Louie AY.

ACS Med Chem Lett. 2011 Jan 1;2(4):285-288.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk